Am J Transplant, Volume 18, Suppl 3 Archives - Page 112 of 211 - ATC Abstracts

2018 American Transplant Congress
Long-Term Follow Up of Living Kidney Donors with CKD at 1 Year after Nephrectomy
J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
¹Department of Urology, Yonsei University College of Medicine, Urological Science Institute, Seoul, Korea; ²Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang-si, Korea; ³Department of Urology, Hanyang University Medical Center, Seoul, Korea; ⁴Department of Surgery-Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Introduction:Many kidney donors show poor recovery after donation and the long-term prognosis of those patients has not been well studied. In this study we explored…
2018 American Transplant Congress
Kidney Transplant Outcome in the Patients with Lupus Nephritis
Y. Kim,¹ H. Lee,¹ H. Chin,² Y. Kim,^3,4 S. Han.¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ²Internal Medicine, Seoul National University Bundang Hopsital, Seong-Nam, Republic of Korea; ³Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea; ⁴Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.
Background: Despite improvements in overall prognosis in lupus nephritis, 10%-30% of patients with proliferative renal involvement progress to end stage renal disease, and kidney transplantation…
2018 American Transplant Congress
Evaluating PROMIS-57 Domains to Screen for Anxiety and Depression Using Legacy Instruments among Kidney Transplant Recipients
A. Bansal,¹ O. Ekundayo,¹ E. Tang,¹ F. Khalafi,¹ H. Ford,¹ M. Li,³ M. Novak,² I. Mucsi.¹
¹Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada; ²Centre for Mental Health, University Health Network, Toronto, ON, Canada; ³Department of Supportive Care, Princess Margaret Hospital, Toronto, ON, Canada.
BACKGROUNDDepression and anxiety are frequent among kidney transplant recipients (KTRs). We evaluate the accuracy of the Patient Reported Outcomes Measurement System (PROMIS 57 item) depression…
2018 American Transplant Congress
Single-Dose Pharmacokinetics and Pharmacodynamics of Belatacept in Adolescent Kidney Transplant Recipients
A. Moudgil,¹ V. Dharnidharka,² D. Feig,³ B. Warshaw,⁴ V. Perera,⁵ B. Murthy,⁵ M. Roberts,⁵ M. Polinsky,⁵ R. Ettenger.⁶
¹Children's National Medical Center, Washington, DC; ²Washington University, St. Louis, MO; ³University of Alabama, Birmingham, AL; ⁴Emory University & Children's Healthcare of Atlanta, Atlanta, GA; ⁵Bristol-Myers Squibb, Lawrenceville, NJ; ⁶University of California, Los Angeles, CA.
Purpose: To assess the pharmacokinetics (PK) and pharmacodynamic (PD) effect of a single dose of belatacept (bela) administered to adolescent kidney transplant recipients (KTR).Methods: In…
2018 American Transplant Congress
Differences in Pediatric and Adult Lost to Follow-Up Events for Heart, Kidney, and Liver Recipients
A. Robinson,¹ G. Mazariegos,² S. Bartosh,³ W. Mahle.⁴
¹United Network for Organ Sharing, Richmond, VA; ²Children's Hospital of Pittsburgh, Pittsburgh, PA; ³University of Wisconsin Hospital and Clinics, Madison, WI; ⁴Children's Healthcare of Atlanta, Atlanta, GA.
Background: Long-term follow-up data are necessary for accurate survival estimation. While the majority of heart (HR), kidney (KI), and liver (LI) transplant recipients (TxR) are…
2018 American Transplant Congress
Long-Term Social Outcome after Pediatric Kidney Transplantation
Y. Hamasaki,¹ T. Matsuda,¹ M. Kubota,¹ J. Hashimoto,¹ Y. Takahashi,¹ M. Muramatsu,² T. Kawamura,³ K. Sakai,² S. Shishido.^1,2
¹Pediatric Nephrology, Toho University Faculty of Medicine, Tokyo, Japan; ²Nephrology, Toho University Faculty of Medicine, Tokyo, Japan; ³Nephrology, Sakura Medical Center, Toho University, Sakura, Japan.
BackgroundPatients' and graft survival rates after pediatric kidney transplantation (KTx) were recently improved because of progress in immunosuppressants, perioperative care, and operative procedures. Therefore the…
2018 American Transplant Congress
TP53 Mutations Lead to Increased Transcription of Circular RNAs in Exosomes Enhancing Tumor Invasiveness in Hepatocellular Carcinoma Bases on Bioinformatics Analysis
Z. Yu, Y. Hou, R. Wang, X. Huang.
The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Objective Increasing evidence suggests that cicular RNAs play an important role in tumor. A recent study found the enrichment of cicular RNAs in HCC derived…
2018 American Transplant Congress
Risk Factors of De Novo Malignancies after Liver Transplantation
M. Altieri,¹ O. Seree,² J. Dumortier,³ GREF2 Groupe de Recherche Français en Greffe de Foie.
¹Service d'HepatoGastroenterologie, Nutrition et Oncologie Digestive, CHU de Caen, Caen, France; ²Réseau Régional de Cancérologie Onco-Basse-Normandie, Herouville Saint-Clair, France; ³Service d'HepatoGastroenterologie, Hospices Civils de Lyon, Hôpital de la Croix Rousse, Lyon, France.
De novo malignancies after liver transplantation (LT) are one of the leading causes of late mortality, with a reported risk of malignancies twice as high…
2018 American Transplant Congress
Intraoperative Blood Loss during Pediatric Liver Transplantation: A Single Center Experience
J. Kohler,¹ D. Yoeli,¹ R. Sigireddi,¹ R. Ackah,¹ M. Kueht,² T. Galvan,² R. Cotton,² A. Rana,² C. O'Mahony,² J. Goss.²
¹School of Medicine, Baylor College of Medicine, Houston, TX; ²Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
Background: The aim of this study is to identify risk factors for massive intraoperative blood loss in pediatric liver transplant recipients and describe its impact…
2018 American Transplant Congress
Transplant Trends in Young Adults: Silent Alcohol Epidemic
N. Kemmer,² N. Bozanich,¹ S. Agrawal,² C. Albers,² R. Syed,² A. Alsina.²
¹Gastroenterology, USF, Tampa; ²Transplant Hepatology, Tampa General Medical Group, Tampa.
With the introduction of effective antiviral therapy for HCV, there is a paradigm shift in liver disease with a decline in HCV but a parallel…